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BACKGROUND: The impact of the Choosing Wisely (CW)
campaign is debated as recommendations alone may not
modify physician behavior.
OBJECTIVE: The aim of this study was to assess whether
behavioral interventions with physician assessment and
feedback during quality circles (QCs) could reduce low-
value services.
DESIGN AND PARTICIPANTS: Pre-post quality improve-
ment intervention with a parallel comparison group in-
volving outpatients followed in a Swiss-managed care net-
work, including 700 general physicians (GPs) and
150,000 adult patients.
INTERVENTIONS: Interventions included performance
feedback about low-value activities and comparison with
peers during QCs. We assessed individual physician be-
havior and healthcare use from laboratory and insurance
claims files between August 1, 2016, and October 31,
2018.
MAIN MEASURES: Main outcomes were the change in
prescription of three low-value services 6 months before
and 6 months after each intervention: measurement of
prostate-specific antigen (PSA) and prescription rates of
proton pump inhibitors (PPIs) and statins.
KEY RESULTS: Among primary care practices, a QC in-
tervention with physician feedback and peer comparison
resulted in lower rates of PPI prescription (pre-post mean
prescriptions per GP 25.5 ± 23.7 vs 22.9 ± 21.4, p val-
ue<0.01; coefficient of variation (Cov) 93.0% vs 91.0%,
p=0.49), PSA measurement (6.5 ± 8.7 vs 5.3 ± 6.9 tests
perGP, p<0.01; Cov 133.5%vs130.7%,p=0.84), aswell as
statins (6.1 ± 6.8 vs5.6 ± 5.4 prescriptions perGP, p<0.01;
Cov 111.5% vs 96.4%, p=0.21). Changes in prescription of
low-value services among GPs who did not attend QCs
were not statistically significant over this time period.
CONCLUSION: Our results demonstrate a modest but
statistically significant effect of QCs with educative feed-
back in reducing low-value services in outpatients with
low impact on coefficient of variation. Limiting overuse in
medicine is very challenging and dedicated discussion
and real-time review of actionable data may help.
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INTRODUCTION
Quality circles (QCs) are small groups of general physicians
(GPs), typically one moderator and five to ten participants
from similar backgrounds, who meet at regular intervals to
discuss and review their clinical practice and solve quality-
oriented medical problems. QCs are an ideal platform to give
individual performance feedback and peer comparisons in a
trusting environment. Interactions between peers promote col-
laborations, partnership, and education to optimize the quality
of care and disseminate best practice guidelines, such as those
published by the Choosing Wisely (CW) campaign.1,2. Since
the launch of this campaign, several medical and surgical
specialty societies have indeed produced top-five lists with
hundreds of recommendations to stimulate conversations be-
tween physicians and patients about unnecessary tests, treat-
ments, and procedures that account for up to 20–30% of all
medical costs.2,3 These top-five lists draw attention to low-
value services, but they must be translated into measurable
recommendations and valid quality indicators if we hope to
assess their effect on physician behavior. Indeed, the dissem-
ination of guidelines alone does not appear to change physi-
cian behavior.4–6
When comparing different approaches to nationwide imple-
mentation of CW recommendations, data measurement is
essential in order to assess whether physicians really follow
the recommendations in their routine clinical practice.7,8 Re-
cent studies have demonstrated the feasibility of directly mea-
suring low-value services that provide minimal benefits for
patients.8,9 An accepted alternative means of assessing physi-
cians’ use of low-value care is to identify variations in medical
practice between physicians.10 Variations in the use of medical
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care can reveal significant differences between regions or
physicians that are warning signs of overuse and strong quality
indicators.9,11,12 Once variation is identified, some behavioral
interventions with data feedback and peer comparison can
result in lower use of low-value care such as inappropriate
antibiotic prescribing for acute respiratory tract infections
among primary care practices.13
The present study examined the use of healthcare services
related to recommendations appearing on top-five lists re-
leased in the Swiss CW campaign3. The aim was to assess
the variation at which use of these low-value services oc-
curred, and to determine whether behavioral interventions
(physician assessment and feedback) during QCs as a support
tool may change the prescription of these low-value services
among primary care practices.
METHODS
Design of the Study
We performed a pre-post intervention study with a parallel
comparison group to compare changes in the use of low-value
services before and after the intervention and thus measure the
impact of the intervention during QCs. The baseline period
included prescriptions that occurred 6 months before the in-
tervention and the post-intervention period also analyzed over
a 6-month period. An additional month-by-month analysis
was performed to evaluate the sustainability of the interven-
tion over time.
Institutional review board approval was granted by the
Commission Cantonale d’Ethique de la Recherche (CCER)
on the Use of Human Subjects.
Study Population
Setting and Inclusion Criteria. We assessed physician
behavior and healthcare use from Delta Network enrollment
and claims files from August 1, 2016, through October 31,
2018, fee-for-service beneficiaries.
The Delta Network is a health maintenance organiza-
tion (HMO) established in the west part of Switzerland
with 4 areas that limit member coverage to medical care
provided through a network of 700 GPs who are under
contract with the HMO. The Delta Network takes care
of more than 250,000 insured adults (>18 years old) and
persons contracting with all Swiss health insurance com-
panies. Delta Network physicians agreed to be account-
able for the quality, cost, and overall care of HMO
beneficiaries who are enrolled in the traditional fee-for-
service program who are assigned to it. All patients who
contracted with Delta Network were included, subject to
data access as the majority, but not all, laboratories and
insurance companies’ partners agreed to transmit the
data, making the information only accessible to approx-
imately 150,000 of 250,000 insured patients.
Data Analysis
Study Variables. We focused on treatments and procedures
that are frequently overused, feasible to change, and in the
domain of the Swiss CW campaign3. Each item could be
analyzed via insurance and laboratory claims data.
– Prescribing rate of proton pump inhibitors (PPIs),
reflecting the CW recommendation to not continue
long-term treatment with proton pump inhibitors without
titrating to the lowest effective dose needed. (A list of
PPIs is available in Appendix 1.)
– Prescribing rate of prostate-specific antigen (PSA) in men
and in subcategory of men >75 years old, reflecting the
CW recommendation to not screen for prostate cancer
without a shared decision discussion and not to screen
over age 75. These data were provided by our partner
laboratory UNILABS which deals with more than 50%
of the requests of the physicians in the network.
– Prescribing rate of statins in patients >75 years old
reflecting the CW recommendation to avoid statins for
primary prevention of nondiabetic patients over age 75.
(A list of statins is available in Appendix 1.)
Behavioral Intervention. Following the implementation of
the Swiss CW campaign 3, thematic QCs were instituted to
target the overuse of low-value services in ambulatory prac-
tices. We considered interventions that have been character-
ized as low-value by the “Swiss CW campaign”.3 These
interventions have been found to provide little to no clinical
benefit on average, either in general or in specific clinical
scenarios. The organization of thematic QCs is described in
Table 1. These thematic QCs took place systematically over a
period of 2–3 months: (i) from February 1 to April 30 2018 for
PPIs, (ii) from February 1 to March 30 2017 for statins, and
(iii) from February 1 to April 30 2017 for PSA. As a first
experience, the QC on PSA required an extended period to
reach all physicians from the network. An additional thematic
QC on PSA was done later in 2017; therefore, the intervention
period was extended from February 1, 2017, to February 28,
2018. During these intervention periods, each physician
attended at least one thematic QC (1-h session) that addresses
each topic separately.
Outcome Measures. The primary outcome was to assess the
mean prescription change of these low-value services within
the network after the behavior interventions. Secondary out-
come was to assess the coefficient of variation (Cov) to
measure the dispersion of data across the mean per GP. The
comparison group was a network of physicians who did not
attend to any QC during the study period.
Data Sources. The data are transmitted to the network by the
insurers within the framework of the health insurance contract
with the Delta Network. Data exchanges between the
insurance company and the network are fully secured (e-mail
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HIN, SFTP with RSA certificate, HTTPS website with dual
authentication). The data used in the current study are an
anonymized version of the initial data.
Statistical Analysis
Descriptive usage analyses were performed (mean, standard
deviation, and median) to describe the study population and
drug and laboratory prescription rates. Data were compared
using t tests for continuous variables and chi-square tests for
categorical variables for matched group, each GP being his
own control before and after the intervention. In order to limit
secular trend, we compared the prescribing behavior of GPs
who did not attend to QC (zero QC) during the same period
with those who benefited from thematic QCs. The coefficient
of variation (Cov) was calculated to indicate the degree of
variation (ratio of the standard deviation to the mean,
expressed as a percentage (%)): a low Cov (usually <15%)
indicates relatively little variation within the sample and a
higher Cov indicates more variation. The test by Forkman
was used to calculate p values of Cov with significance level
at 0.05. No attempt at imputation of missing data was carried
out. All analyses were performed using SAS version 9.4
(Cary, NC, USA).
RESULTS
Demographics data of GPs who attended QCs are depicted in
Table 2. Data were similar to those who did not attend QCs on
each intervention, except a higher percentage of woman phy-
sicians in the former group (Appendix 2).
PPIs
A total of 28,750 PPI prescriptions were filled by 483 GPs
participating in a QC during the study period. Thematic QCs
on PPI prescription were conducted from February 1, 2018, to
April 30, 2018 (3 months of behavior intervention). In the pre-
intervention period, an average of 25.5 ± 23.7 (median: 19.0)
prescriptions per GP were filled compared to 22.9 ± 21.4
(median: 18.0) in the post-intervention period (p≤0.01) (Fig.
1). In total, 52.0% of physicians decreased the number of
prescriptions following the intervention period. The coeffi-
cient of variation was not significantly different between the
pre- and post-intervention (93.0% vs 91.9%, p=0.49).
In comparison, the group of physicians (n=265) who did not
attend the behavior intervention QC prescribed 11,700 PPIs
during the study period without a significant change over time
(18.2 ± 25.0 (median: 19.0) pre-intervention prescriptions per
GP vs 17.4 ± 36.0 (median: 18.0) post-intervention prescrip-
tions, p=0.54).
PSA prescription
During the study period, 3484 PSA tests were prescribed by
118 GPs. The thematic QC with data feedback on PSA pre-
scription took place from February 1 to April 30 2017 (3
months of behavior interventions) but since there were addi-
tional thematic QCs later in 2017, the intervention period was
extended from February 1, 2017, to February 28, 2018. In the
pre-intervention period, the mean PSA prescription per GP
was 6.5 ± 8.7 (median 3.0) as significantly higher compared to
5.3 ± 6.9 (median 3.0) in the post-intervention period (p=0.03)
(Fig. 1). In total, 56.0% of physicians decreased the number of
prescriptions following the intervention period. The coeffi-
cient of variation was 133.5% for the pre-intervention period
and 130.7% for the post-intervention period (p=0.84).
When restricting this analysis to patients >75 years old
(total of 273 PSA prescriptions by 61 physicians), results were
similar (2.7 ± 2.7 prescriptions per GP in the pre-intervention
period compared to 1.8 ± 2.1 in the post-intervention period
(mean difference: p=0.04). The coefficient of variation was
101.2% in the pre-intervention period to 114.2% in the post-
intervention period (p=0.50).
In comparison, the group of physicians (n=32) who did not
attend the behavior intervention QCs did 621 PSA tests during
Table 1 Thematic Quality Circle (QC) Process Step-by-Step
1. Identification of a situation of low-value service
2. Creation of clinical case scenario
3. Presentation of the clinical case during the QC by the moderator
4. Participants are invited to give their opinion and behavior in the situation presented, without intervention of the moderator
5. The moderator uses variation in care between participants to start the discussion and presents the latest recommendations for good clinical practice
6. Data reporting on variation of low-value services within the network and benchmarking at participants and the QC level
7. Discussion of intervention measures to avoid use of the low-value service within the group (nudge, clinical decision tool)













51.3 ± 9.8 59.9 ± 5.5 52.7 ± 9.3
Women 314 (24.0%) 50 (33.3%) 258 (40.4%)
Network area
1 10 (1.3%) 0 (0.0%) 1 (0.2%)
2 446 (59.7%) 127 (84.7%) 392 (61.3%)
3 18 (2.4%) 0 (0.0%) 10 (1.6%)
4 273 (36.6%) 23 (15.3%) 235 (36.8%)
Years since
graduation
25.8 ± 9.9 32.6 ± 7.1 26.5 ± 10.0
≤ 5 years 1 (0.78) 0 (0.0%) 1 (0.8%)
> 5 years ≤
10 years
6 (4.7%) 0 (0.0%) 5 (3.9%)
> 10 years 121 (95.5%) 35 (100.0%) 122 (95.3%)
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the study period without any significant change over time (2.9
± 3.6 per GP vs 3.8 ± 3.5 per GP, p=0.19).
Statins
A total of 15,692 statin prescriptions were filled by 384 GPs
participating in a QC during the study period. Thematic QCs
on statin prescription were conducted from February 1, 2018,
to March 31, 2017 (2 months of behavior intervention).
In the pre-intervention period, for patients >75 years old, an
average of 6.1 ± 6.8 (median: 4.0) prescriptions per GP were
filled compared to 5.6 ± 5.4 (median: 4.0) in the post-
intervention period (p<0.01) (Fig. 1). There was not a signif-
icant change among physicians who did not attend a QC (5.6 ±
6.8 per GP pre-intervention vs 5.4 ± 6.7 per GP post-
intervention (p=0.29).
In total, 47.5% of physician decreased the number of pre-
scriptions following the intervention period. The coefficient of
variation was 111.5% in the pre-intervention period and
96.4% in the post intervention period (p=0.21).
DISCUSSION
This study is the first to evaluate the impact of QCs as an
additional tool to implement recommendations from the CW
campaign using region-wide population-level data from insur-
ance and laboratory claims in Switzerland. Our results suggest
that among primary care practices, thematic QC intervention
with data feedback and peer comparison resulted in lower
mean of PPI prescription (25.5 ± 23.7 per GP vs 22.9 ± 21.4
per GP, p<0.01), PSA (6.5 ± 8.7 per GP vs 5.3 ± 6.9 per GP,
p=0.03), and statin prescriptions over age 75 years (6.1.0 ± 6.8
per GP vs 5.6 ± 5.4 per GP, p<0.01). Decreases in prescrip-
tions were similar when restricting the analysis for 75 years
old for PSA. The majority of physicians decreased their num-
ber of prescriptions following the intervention period (52% for
IPP, 56.0% for PSA, and 64.0% for statin). Conversely, we did
not observe significant decreases in the comparison group who
did not attend QCs suggesting that observed differences can-
not be explained by secular trends in decreasing number of
prescriptions. The coefficient of variation was very high
among study groups indicating a large dispersion of prescrip-
tion rate. This coefficient decreased after the intervention but
without reaching statistical significance.
Measuring the impact of CW efforts to eliminate waste in
healthcare is complex and requires a variety of approaches.
Simply informing doctors to order tests parsimoniously has
limited effect given administrative barriers to change and
accurate documentation remain suboptimal. 7,14 Creating the
CW top-five lists raised awareness among different stake-
holders but it was only a first step: such lists must be translated
into measurable recommendations to assess their effect on
changing behavior. 6,15,16 Subsequently, CW published a
framework based on physician attitudes, behaviors, and pa-
tient engagement to measure its effectiveness going for-
ward.17,18 Without robust and reliable data reporting, most
physicians cannot appreciate the extent to which they are
contributing to overuse. Accessing claims data in our study
allowed an evaluation of CW recommendations on low-value
services based on region-wide population-level data and on a
practical level. Only few data have assessed effectively the
impact of CW campaign in ambulatory setting. A US analysis
of database compensation claims published in 2015 examined
the impact of seven CW recommendations with contrasting
results: there were clinically significant reductions in two tests
(imaging for headache, cardiac imaging), a small increase in
two recommendations (nonsteroidal anti-inflammatory drug
use and screening of very young women for the human pap-
illomavirus), and statistically significant but clinically insig-
nificant decreases in the remaining measures.6
Dissemination of guidelines by itself is insufficient to drive
practice change, which requires more robust implementation
strategies in regard to the complexities of different practice
environments. There is an increasing interest in the use of
behavioral science to affect practice in medicine. Reporting
performance data back to physicians with educative feedback
Figure 1 Change in the average number of prescriptions per GP of three low-value measures per GP before and after behavioral interventions.
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can be used as a “radar sensor effect” similar to traffic con-
trolling, in order to nudge physicians’ behaviors.15,19 Our
pragmatic quality improvement study introduced the use of a
behavioral intervention with data feedback during QCs to
reduce low-value services in the outpatient setting.
QCs are an ideal platform and context to provide personal
performance feedback and peer comparisons. Even if report-
ed effectiveness for improving quality in healthcare varies
substantially among studies assessing their impact, QCs are a
vehicle for discussing issues and reflecting on practice. 1,20
QCs may also improve individual and group performance by
reducing costs, encouraging professionals to order fewer but
more appropriate tests, improving prescription habits, and
reporting critical incidents20. During QCs, dedicated discus-
sion and review time of actionable data may help to dissem-
inate best practice guidelines, such as the top-five lists
published by the CW campaign. A study confirmed that data
reporting with educative feedback has a positive effect and
reduced the level of inappropriate care.13 In that study, the
use of accountable justification and peer comparison as
behavioral interventions resulted in lower rates of inappro-
priate antibiotic prescribing for acute respiratory tract infec-
tions among primary care practices.13 Audit and feedback
combined with multifaceted outreach education for
healthcare professionals have also been successful in primary
care in Australia.21
One of the challenges in measuring progress in reducing
overuse is to identify when a service was provided inappro-
priately because the definition of appropriateness of a service
often includes knowing about symptoms and physical exam
findings often not included in administrative databases. Fur-
thermore, many of the CW recommendations are clinically
nuanced, and data systems lack the precision to measure
accurately. To address the issue of appropriateness, we also
assessed the Cov of these low-value services as a secondary
outcome that reveals to be lower after our intervention but did
not reach statistical significance. Clinical variation is an ac-
cepted way to identify potential overuse in medicine among
practitioners.11,22 Variation analyses can show significant dif-
ferences that are warning signs of overuse and a strong quality
indicator. Clinical variation can act as catalysts for change by
stimulating debate, engaging all participants in the health
system so that patient-focused care can be achieved.11 Process
standardization can dramatically decrease variation and even-
tually improve performance.22,23 Furthermore, the case mix of
studied populations has little importance when interpreting
variation results, which avoids some bias and makes
benchmarking between physician easier. Our low impact on
coefficient of variation reflects the challenge of changing
clinician decision-making, particularly in the ambulatory set-
ting. As we do not have yet access to diagnoses and clinical
context through electronic health records, we gave feedback to
physicians about their performance based on utilization data,
using the variation of practice among physicians as estimates
of appropriate adherence.
Limitations of the Study
Our study has several limitations. Our analysis is based on
administrative claims data that do not adequately capture the
clinical circumstances that led to ordering a service, which
may be essential for some recommendations, such as implying
a shared decision-making process like PSA test measurement.
Therefore, we cannot affirm these interventions were inappro-
priate for all individual patients. To assess the variability of
our findings across a spectrum of these important measure-
ment properties, we stratified the measures of PSA dosage by
age (>75 years old), for detecting low-value care. Limiting the
prostate cancer screening measure to beneficiaries over age 75
instead of 50 increases its specificity of being inappropriate
(smaller proportion of appropriate services misclassified as
inappropriate).
The relative decrease of variation may reflect a standardi-
zation of medical use but does not permit to distinguish
inappropriate from appropriate use. Besides, some variation
in healthcare delivery is warranted and desirable, such as
meeting differences in patients’ health needs or health
preferences.
Notwithstanding the issue of appropriateness and measure-
ment, our intervention studies focus on a brief period after the
change, limiting the capacity of physician to modify their
practice and deprescribe some drugs such as statin. Further-
more, even if we did comparison with a group of physicians
who did not attend the behavioral intervention, it is possible
that other factors may have been responsible for changes of
low-value services such as different case mix or the numbers
of visits per GP. Self-selection of physicians likely introduced
a selection bias, as clinicians participating in QCs are probably
more amenable to changing their practice patterns than our
comparison group that did not participate in QCs. Further-
more, a Hawthorne effect—the tendency for some to perform
better when they perceive that their work is under
scrutiny—may at least partly explain the observed positive
effect of the thematic QC in our study. Eventually, our com-
parison group was quite small, limiting statistical precision for
before-after comparisons.
CONCLUSION
The central goal of the CW campaign was to change the
culture of medical care that has historically supported overuse
of unnecessary tests, treatments, and procedures. This study
using an educative data feedback during QCs as a support tool
provides a starting point for further evaluation of the influence
of the initiative on changing behavior by analyzing changes in
volume and variation of these low-value services. Educative
feedback can provide the opportunity for physicians to carry
out analyses of their own practices and to see whether there are
opportunities for implementing higher value practices. The
relatively modest change suggests though that additional
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long-term interventions are necessary for wider implementa-
tion of CW campaign.
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